Projects per year
Personal profile
Education
- 2006-2012 Ph.D., Department of Pharmacy, National Taiwan University
- 2005-2006 M.S., Department of Pharmacy, National Taiwan University
- 2000-2005 B.S., Department of Pharmacy, National Taiwan University
Experience
- 2020.08- Associate Professor, Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University
- 2016.03-2020.07 Assistant Professor, Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University
- 2016.01-2016.03 Postdoctoral Research Fellow, Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2013.07-2014.02 Postdoctoral Research Scholar, Academia Sinica
- 2012.02-2013.06 Postdoctoral Research Fellow, National Taiwan University
Awards
- 2019 Young Researcher Award, Taipei Medical University
Research Interests
- 藥理及毒理
- 藥學
Fingerprint
Dive into the research topics where Chun-Han Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting Pparγ by Bufadienolides as a New Therapeutic Strategy in Luminal-Type Bladder Cancer
Chen, C.-H. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Anti-Bladder Cancer Therapy from Bufadienolides by Targeting Metabolic Reprogramming.
Chen, C.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Investigating the Therapeutic Potential and Molecular Mechanism of Natural Products in Pediatric High-Grade Gliomas
Chen, C.-H. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
蓮子心生物鹼對於兒童神經膠母細胞瘤影響細胞凋亡以及上皮-間質轉化之機轉探討
Chen, C.-H. (PI)
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
Investigating the Therapeutic Potential and Molecular Mechanism of Natural Products in Pediatric High-Grade Gliomas (2/3)
Chen, C.-H. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer
Lin, Y. C., Chu, C. Y., Hsieh, T. H., Lin, B. J., Liou, J. P., Yen, Y. & Chen, C. H., Dec 2025, In: Cell Death and Disease. 16, 1, 485.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Hinokiflavone is a novel CK2 inhibitor promoting apoptosis and synergizing with chemotherapeutic agents in cisplatin resistant bladder cancer cells
Hsieh, T. H., Kuo, H. P., Chen, M. C., Lin, Y. C., Lin, B. J., Hsu, K. C. & Chen, C. H., Dec 2025, In: Scientific Reports. 15, 1, 20922.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Correction to: The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells (Cell Death & Disease, (2013), 4, 9, (e810), 10.1038/cddis.2013.330)
Chen, M. C., Chen, C. H., Wang, J. C., Tsai, A. C., Liou, J. P., Pan, S. L. & Teng, C. M., Jul 2024, In: Cell Death and Disease. 15, 7, 490.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Targeting CK1δand CK1ϵ as a New Therapeutic Approach for Clear Cell Renal Cell Carcinoma
Lin, Y. C., Sun, D. P., Hsieh, T. H. & Chen, C. H., Dec 1 2024, In: Pharmacology. 109, 6, p. 330-340 11 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer
Tu, C. C., Hsieh, T. H., Chu, C. Y., Lin, Y. C., Lin, B. J. & Chen, C. H., Dec 2024, In: Cell Death and Disease. 15, 12, 908.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)